Assessing the views and opinions of psychiatric patients receiving genome-guided treatment within the scope of the PREPARE preemptive pharmacogenomics clinical study
Collectively, our data highlights the need for enhanced patient education and awareness about PGx testing and reflects an overall positive patient attitude towards genome-guided therapeutics.
Authors
- Marc S. Williams (ORCID: https://orcid.org/0000-0001-6165-8701)
- Μαρία Σκώκου (ORCID: https://orcid.org/0000-0002-8579-8933)
- Christina Mitropoulou (ORCID: https://orcid.org/0000-0002-9184-4668)
- George P. Patrinos (ORCID: https://orcid.org/0000-0002-0519-7776)
- Kariofyllis Karamperis (ORCID: https://orcid.org/0000-0002-3085-7799)
- Margarita-Ioanna Koufaki (ORCID: https://orcid.org/0000-0001-8152-3185)
- Konstantinos Vasileiou (ORCID: https://orcid.org/0000-0002-8341-0261)
- Maria‐Theodora Pandi
Institutions
- Geisinger Medical Center (US)
- University of Patras (GR)
- United Arab Emirates University (AE)
- Erasmus MC (NL)
- Golden Helix Foundation (GB)
- Pasteur Hellenic Institute (GR)
- Zayed University (AE)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.3389/fphar.2025.1722339
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Patras
- European Commission